Our Agentic AI-enabled Generative AI services empower enterprises to create, adapt, and scale intelligent systems capable of automating workflows and making autonomous decisions. Built in alignment with ISO 42001 AI management standards, our solutions ensure governance, trust, and compliance while delivering transformative business value. Leveraging cutting-edge technologies like GPT-4, LLaMA, and PaLM-2, our data scientists develop tailored solutions using deep learning, machine learning, computer vision, and natural language processing.
Whether it’s streamlining R&D in manufacturing, enabling dynamic customer engagement in retail, accelerating diagnostics in healthcare, or automating operations in finance, our Agentic AI-powered generative solutions are helping enterprises unlock unprecedented levels of creativity, precision, and autonomy.
Experienced in building adaptive, goal-driven Generative AI systems using cutting-edge Agentic AI technologies.
Proven track record of 600+ AI deployments integrated into clinical, industrial, financial and logistics workflows.
Deep integration experience with Redox, FHIR, HL7, and IoT protocols across cloud-native Agentic ecosystems.
Rapid co-creation of tailored Agentic solutions aligned with business goals and measurable KPIs.
Vision applications that evolve through interaction, improving performance, usability, and real-world applicability.
Human-in-the-loop design, explainable outputs, and compliance-driven frameworks ensure trust and accountability.
Deployed for a US healthcare firm, our Agentic Generative AI chatbot enhances patient experiences by autonomously engaging with diverse content formats (PDF, Word, Excel). It intelligently retrieves and contextualizes information, enabling patients and staff to seamlessly interact with healthcare resources. The result: faster information access, improved communication, and a more user-friendly, always-available support system.
Applied to drug discovery research, our Generative AI system autonomously processes complex medical reports and synthesizes critical insights, such as Phase 1 trial data for candidate therapeutics. By distilling vast datasets into concise, actionable summaries, it accelerates decision-making for researchers, clinicians, and stakeholders, fueling innovation, reducing analysis time, and enabling faster breakthroughs in medical science.
Engineered for a European enterprise, this Agentic AI-enabled Gen AI negotiation engine autonomously optimizes end-user negotiations, accelerating response times and tailoring strategies in real time. By streamlining the process and fostering highly relevant, data-backed communication, it boosts sales performance, strengthens client relationships, and transforms negotiation efficiency, resulting in faster deals and increased revenue.
Generative AI is transforming the field of artificial intelligence by simulating human speech and decision-making. Its potential to revolutionize various industries, including production design, design research, visual identity, branding, copy creation, and real-time personalization, is immense. However, organizations are unsure whether they are ready for Generative AI, as there are concerns about striking a balance between AI and human work.
Although the generative ai and future of work has already grown rapidly, there is still much more to come. According to data, the future of generative AI market is projected to reach a size of around $241 billion by 2033, up from $5 billion in 2023, at a CAGR of 47.3% in the US alone.
Generative AI in clinical trials has potential because these trials should be cost-effective, versatile, and adaptable to meet the varied objectives of different stakeholder groups. The complexities of clinical trials, which are labor-intensive, complex, and highly regulated by nature, make this more difficult in today’s challenging economic environment.
